AGM, page-34

No worries from me cake. Id get eaten alive arguing a case against ACLs management - no background in finance at all.
Should be an interesting morning. I personally doubt there will be anything significant to announce. I think they will stick to the timeframes - another 4 weeks to review data and start of next year for strategic direction.
I cant see the end of Hyact. Seems to be too much clinical evidence around to support its potential. If I had to predict the future Id say 3-4 years time we will be waiting for the outcome of another phase 3 - probably diluted to the max as well. I do hope a partner comes on board and shares the cost.

Either way, spent the last two weeks beating myself up over the trial outcome. A few long walks in the bush have been therapeutic.

I reckon 2c up or 2c down tomorrow.